A

Advaxis, Inc.

44 employees

Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Cervical Cancer
Infectious Disease
Head and Neck Cancer
Oncology
Pharmaceutical
Personalized Medicine
HPV
Health Diagnostics
Immunotherapy
Prostate Cancer
Anal Cancer
Microcap

Date founded

2002

Funding rounds raised

Total raised

$23M

from 3 investors over 3 rounds

A

Advaxis, Inc. raised $23M on February 19, 2015

Investors: Sectoral Asset Management, Adage Capital Management and T. Rowe Price

FAQ